drugset / Trial / NCT06322394
BXOS110 Injection in the Treatment of Acute Ischaemic Stroke
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study was to evaluate the effectiveness of early administration of BXOS110 for injection in reducing overall disability in patients with acute ischaemic stroke.
Timeline
- Start
- 2024-02-07
- Primary completion
- 2025-03
- Completion
- 2025-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BXOS110 | Unknown | 2 mg/kg | Intravenous |
| Subject | BXOS110 | Unknown | 3 mg/kg | Intravenous |